000 | 02013 a2200637 4500 | ||
---|---|---|---|
005 | 20250517131743.0 | ||
264 | 0 | _c20180216 | |
008 | 201802s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.14013 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKiechl, Stefan | |
245 | 0 | 0 |
_aAberrant regulation of RANKL/OPG in women at high risk of developing breast cancer. _h[electronic resource] |
260 |
_bOncotarget _cJan 2017 |
||
300 |
_a3811-3825 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aBreast Neoplasms _xblood |
650 | 0 | 4 | _aEarly Detection of Cancer |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplastic Cells, Circulating _xmetabolism |
650 | 0 | 4 |
_aOsteoprotegerin _xblood |
650 | 0 | 4 | _aPostmenopause |
650 | 0 | 4 |
_aProgesterone _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRANK Ligand _xblood |
650 | 0 | 4 |
_aReceptor Activator of Nuclear Factor-kappa B _xblood |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aSchramek, Daniel | |
700 | 1 | _aWidschwendter, Martin | |
700 | 1 | _aFourkala, Evangelia-Ourania | |
700 | 1 | _aZaikin, Alexey | |
700 | 1 | _aJones, Allison | |
700 | 1 | _aJaeger, Bernadette | |
700 | 1 | _aRack, Brigitte | |
700 | 1 | _aJanni, Wolfgang | |
700 | 1 | _aScholz, Christoph | |
700 | 1 | _aWilleit, Johann | |
700 | 1 | _aWeger, Siegfried | |
700 | 1 | _aMayr, Agnes | |
700 | 1 | _aTeschendorff, Andrew | |
700 | 1 | _aRosenthal, Adam | |
700 | 1 | _aFraser, Lindsay | |
700 | 1 | _aPhilpott, Susan | |
700 | 1 | _aDubeau, Louis | |
700 | 1 | _aKeshtgar, Mohammed | |
700 | 1 | _aRoylance, Rebecca | |
700 | 1 | _aJacobs, Ian J | |
700 | 1 | _aMenon, Usha | |
700 | 1 | _aSchett, Georg | |
700 | 1 | _aPenninger, Josef M | |
773 | 0 |
_tOncotarget _gvol. 8 _gno. 3 _gp. 3811-3825 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.14013 _zAvailable from publisher's website |
999 |
_c26720552 _d26720552 |